Trial description
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events (MACEs) in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix (GnRH Receptor Antagonist) or Leuprolide (GnRH Receptor Agonist)
Contact name
Dr Danish Mazhar
Trial start date
Wednesday, September 11, 2019
Trial end date
Tuesday, June 30, 2020
Trial tumour type
Show on Radiotherapy